Safety and efficacy of addition of VEGFR and EGFR-family oral small-molecule tyrosine kinase inhibitors to cytotoxic chemotherapy in solid cancers: A systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Safety and efficacy of addition of VEGFR and EGFR-family oral small-molecule tyrosine kinase inhibitors to cytotoxic chemotherapy in solid cancers: A systematic review and meta-analysis of randomized controlled trials

Published:2014-06 Issue:5 Volume:40 Page:636-647
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Funakoshi Tomohiro,Latif Asma,Galsky Matthew D.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference89 articles.

1. Small molecule tyrosine kinase inhibitors in the treatment of solid tumors: an update of recent developments;Steeghs;Ann Surg Oncol,2007

2. Erlotinib in previously treated non-small-cell lung cancer;Shepherd;N Engl J Med,2005

3. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

4. Sorafenib in advanced clear-cell renal-cell carcinoma;Escudier;N Engl J Med,2007

5. Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial;Sternberg;J Clin Oncol,2010

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A subset of VEGFR‐TKIs activates AMPK in LKB1 ‐mutant lung cancer;Cancer Science;2022-12-18

2. Disrupting cancer angiogenesis and immune checkpoint networks for improved tumor immunity;Seminars in Cancer Biology;2022-11

3. Metastatic medullary thyroid carcinoma: a new way forward;Endocrine-Related Cancer;2022-07-01

4. Construction of a novel bispecific fusion protein to enhance targeting for pancreatic cancer imaging;Biomaterials;2020-10

5. Impact of repeated cycles of EGF bispecific angiotoxin ( eBAT ) administered at a reduced interval from doxorubicin chemotherapy in dogs with splenic haemangiosarcoma;Veterinary and Comparative Oncology;2020-04-02